Pure Global

ALT GPT (BIOLABO ALT GPT ) - India CDSCO Medical Device Registration

ALT GPT (BIOLABO ALT GPT ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000051_db5f3206aca305f7eb1bf429ed557d05_cafa7011139aeef407c84539cb4809e9. This device is marketed under the brand name BIOLABO ACID CALCIUM Arsenazo III Method. The license holder is Wheecon Instruments Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
ALT GPT (BIOLABO ALT GPT )
UID: IMP/IVD/2023/000051_db5f3206aca305f7eb1bf429ed557d05_cafa7011139aeef407c84539cb4809e9

Brand Name

BIOLABO ACID CALCIUM Arsenazo III Method

Device Class

Class B

Approving Authority

CDSCO

Product Information

ALT is present in very high amounts in liver and kidney, and in smaller amounts in skeletal muscle and heart. Although serum levels of both AST and ALT become elevated whenever diseases process affecting liver cells integrity, ALT is the more liver-specific enzyme. A serum elevation of ALT activity is rarely observed in conditions other than parenchymal liver disease (BIOLABO ACID CALCIUM Arsenazo III Method). Moreover, its elevation persists longer than do those of AST activity. Measurement of both AST and ALT has some value in distinguishing hepatitis from other parenchymal lesions

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing